Platinum Sponsors
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca’s innovative medicines are sold in more than 125 countries and used by millions of patients worldwide.
- www.astrazeneca.com
- Booth no. 01
Merck
Merck is a leading science and technology company in healthcare, life science and performance materials, working to make a positive difference to millions of people’s lives every day. Merck holds the global rights to the Merck name and brand. Exceptions: US and Canada, where the company operates as EMD Serono, MilliporeSigma, EMD Performance Materials, MilliporeSigma and EMD Performance Materials.
- www.merckgroup.com
- Booth no 06
MSD
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
- www.msd.com
- Booth no. 04
Servier
Founded to serve health and support patients, Servier is a global pharmaceutical group governed by a Foundation. Aiming to become a focused player in oncology, we allocate over 70% of our R&D budget to developing targeted and innovative therapies in oncology (currently 19 projects in clinical development), with a focus on rare cancers.
Gold Sponsors
AbbVie Inc.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
Amgen
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases. We discover, develop, manufacture, and deliver innovative medicines to help millions of patients. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases.
Astellas Pharma Inc.
Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into VALUE for patients.
BMS
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram.
Daiichi Sankyo, Inc
With more than 120 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 17,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.
Eisai
At Eisai EMEA, everything we do is dedicated to giving our first thought to patients and their families through our human health care (hhc) philosophy. We are the European hub of Tokyo-based Eisai Co. Ltd., forming part of a multinational team working across a global network of R&D facilities, manufacturing sites and marketing subsidiaries.
Gilead Oncology
Gilead Oncology are working to transform how cancer is treated. From ADCs and small molecules to cell therapy-based approaches, our portfolio and pipeline assets are creating new possibilities for people with cancer.
Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing potentially life-changing medicines for people with serious diseases — often with limited or no therapeutic options. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience.
Novocure GmbH
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields (TTFields). TTFields are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms.
Pierre Fabre Laboratories
Pierre Fabre Laboratories one of Europe's leading pharmaceutical companies has over 40 years in oncology innovation. In 2023, 50% of R&D budget was allocated to targeted therapies. Its portfolio of oncology specialties covers colorectal, breast, lung and skin cancers, as well as hematologic malignancies and precancerous dermatological conditions such as actinic keratosis.
Revolution Medicines
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
Takeda Pharmaceuticals
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere.
Silver Sponsors
BeiGene
BeiGene, which plans to change its name to BeOne Medicines, is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. Our growing global team of nearly 11,000 colleagues spans five continents.
Pfizer Oncology
Pfizer Oncology is at the forefront of a new era in cancer care. Driven by science, we are committed to accelerating breakthroughs to help people with cancer live better and longer lives.
Roche
Roche is a pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, hematology and beyond.
Supporter
Eli Lilly and Company
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people.
Exhibitor
Nordic Pharma
Nordic Pharma’s oncology division specializes in chemotherapy for gastrointestinal cancer, prioritizing enhanced quality of life for patients. Through leveraging a combination of real-world evidence and innovative research, we're dedicated to advancing treatment options that improve outcomes and well-being. Join us in our mission to redefine the standards of care in gastrointestinal oncology.
Educational Grant
Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.